Session Overview
- With rising medical utilization, diminished prior auth, and greater inflationary pressures, health plans now more than ever must adopt innovation to prevent spend on fraud, waste and abuse (FWA). FWA reduction offers a huge opportunity to improve spend and member outcomes – by reducing unnecessary spend and aligning providers with best practices to avoid waste and harm. With new advances in FWA detection, plans can now improve their ability to reduce payment on FWA claims with tools that analyze patient data and provider patterns to precisely identify the services that might be wasteful or abusive.
During this case study, ATRIO Health Plans and Health at Scale will discuss the impact seen from implementing smart, context-aware FWA flagging into pre-adjudication along with a targeted provider education campaign and how the team was able to successfully drive down medical spend by 1.8% in the first year.
Learning Objectives/Key Takeaways of the Session
- Learn how ATRIO Health Plans crafted an innovative new FWA detection program and the factors that led to their substantial spend improvement
- See how new advances in FWA detection improve upon traditional systems by considering real-time context about individual patient history, provider patterns, and medical guidelines to determine if a service is appropriate
- Learn how FWA flagging in pre-adjudication can be supplemented with a targeted provider education program to align provider practices with best standards of care
Jennifer Callahan
Jen Callahan is the President and Chief Operating Officer of ATRIO Health Plans. For over 20 years, Jen has established herself as a trusted thought leader who helped shape the managed care industry with her innovative ideas and expertise. Jen has dedicated her career almost exclusively to Medicare Advantage and Medicare Supplement programs.
Prior to joining ATRIO, she co-founded a field management organization, Keen Insurance Services, Inc. to create a provider-centric Medicare focused sales and distribution organization from the ground up. Prior to that, she held the position of Vice President, Medicare Product at Aetna, a CVS Health company where she oversaw the product development and implementation of Aetna’s entire Medicare portfolio supporting record breaking growth for the Medicare organization. Throughout her career, Jen has also held various leadership positions at Healthfirst and Elevance.
Jen received her Bachelor of Science degree from Fordham University and MBA from North Carolina State University. Jen currently resides in Waxhaw, a suburb of Charlotte, North Carolina with her husband, their three kids, tuxedo cat, Vivi and golden retriever puppy, Steve.
Zeeshan Syed
Zeeshan serves as Health at Scale’s CEO and was a Clinical Associate Professor at Stanford Medicine and an Associate Professor with Tenure in Computer Science at the University of Michigan. He was previously part of the early stage team that launched Google[X] Life Sciences (now Verily). Zeeshan is a recipient of multiple awards including an NSF CAREER award and holds a PhD from MIT EECS and Harvard Medical School in Computer Science and Biomedical Engineering, and MEng and SB degrees in EECS from MIT.